Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
LXRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading LXRX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.27%155.011.1%$478.85m
GILDGilead Sciences, Inc.
-0.09%64.500.9%$468.51m
REGNRegeneron Pharmaceuticals, Inc.
-0.12%455.172.7%$416.76m
CELGCelgene Corporation
0.03%116.781.1%$407.52m
ALXNAlexion Pharmaceuticals, Inc.
-0.81%97.701.9%$373.58m
BIIBBiogen Inc.
-0.86%250.801.2%$355.62m
INCYIncyte Corporation
-2.91%134.382.6%$286.18m
PBYIPuma Biotechnology, Inc.
2.18%79.7521.1%$224.97m
VRTXVertex Pharmaceuticals Incorporated
1.11%119.921.9%$192.01m
ILMNIllumina, Inc.
1.24%175.913.5%$175.81m
AAgilent Technologies, Inc.
0.35%59.511.5%$135.41m
EXASExact Sciences Corporation
0.39%33.3228.0%$128.17m
TSROTESARO, Inc.
-2.66%149.1114.7%$108.95m
KITEKite Pharma, Inc.
-2.40%73.1116.1%$106.96m
BMRNBioMarin Pharmaceutical Inc.
0.77%88.004.4%$97.75m

Company Profile

Lexicon Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.